Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.

• Main Authors: Jonathan D King (Author), Tesfaye Teferi (Author), Elizabeth A Cromwell (Author), Mulat Zerihun (Author), Jeremiah M Ngondi (Author), Mesele Damte (Author), Frew Ayalew (Author), Zerihun Tadesse (Author), Teshome Gebre (Author), Ayelign Mulualem (Author), Alemu Karie (Author), Berhanu Melak (Author), Mitku Adugna (Author), Demelash Gessesse (Author), Abebe Worku (Author), Tekola Endashaw (Author), Fisseha Admassu Ayele (Author), Nicole E Stoller (Author), Mary Rose A King (Author), Aryc W Mosher (Author), Tesfaye Gebregzabher (Author), Geremew Haileysus (Author), Peter Odermatt (Author), Jürg Utzinger (Author), Paul M Emerson (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2014-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts. Prevalence surveys to assess impact at the dist...